Healthy subjects
Conditions
Interventions
12-week intake of the containing PQQ 2Na food of 1 capsules a day
2-week intake of the placebo food of 1 capsules a day
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Healthy individuals without serious disease 2)Regardless of gender 3)Patients aged 20 years or older to 65 years or younger who voluntarily wish to participate in clinical trials and obtain written consent. 4)Patients who can maintain a constant lifestyle during the study period 5)Subjects being treated for mild chronic illness (e.g., hypertension, hyperlipidemia) may participate in the study at the discretion of the investigator. 6)Patients who have a MMSE score of 24 or more
Exclusion criteria
Exclusion criteria: 1)Patients suffering from serious liver and kidney disease, heart disease, respiratory disorders, endocrine disorders, diabetes mellitus, food allergy, drug allergy, cancer, dementia and psychiatric disorders 2)Patients allergic to gelatin 3)Patients who wish to be pregnant, lactating, or pregnant during the study period 4)Patients who have ingested PQQ 2Na within 3 months before the test 5)Patients who are deemed ineligible to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitrax and task memory tests | — |
Secondary
| Measure | Time frame |
|---|---|
| BDNF and Overall body composition by In body | — |
Countries
Japan
Contacts
Public ContactDaisuke Ochitani
HUMA R&D CORP Clinical Development Division
Outcome results
None listed